Filed: 2/13/2024ACC: 0001507673-24-000002
📋 What this filing means
RP MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $148.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$148.72M
Total AUM (reported)
6.79M
Total Shares
Allocation by class
COM$148.72M100.0%
Portfolio Concentration
Top 3$148.72M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.79M
Sole
Full voting authority
6.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BIOHAVEN LTD
DFNDShares2.94M
TypeSH
Market value$125.68M
84.51%
Sole
2.94M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
DFNDShares3.85M
TypeSH
Market value$23.04M
15.49%
Sole
3.85M
Shared
0.00
None
0.00
VIRACTA THERAPEUTICS INC
DFNDShares3.70K
TypeSH
Market value$2.1K
<0.01%
Sole
3.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOHAVEN LTDDFND | COM | 2.94M | SH | $125.68M 84.51% | 2.94M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCDFND | COM | 3.85M | SH | $23.04M 15.49% | 3.85M | 0.00 | 0.00 |
VIRACTA THERAPEUTICS INCDFND | COM | 3.70K | SH | $2.1K <0.01% | 3.70K | 0.00 | 0.00 |